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A Matched Molecular Pair (MMP) is a pair of com-
pounds which differ only by a well-defined structural
transformation [1,2]. Together with large-scale mining
of activity or physicochemical data, matched molecular
pair analysis (MMPA) has the potential to aid the design
of molecules with improved properties by highlighting
favourable transformations.
Here we greatly enhance the performance of MMPA
for activity prediction by extending to Matched Mole-
cular Series [3,4]. While matched pair transforms are
typically equally likely to increase activity as decrease
it, series of length 3 or more exhibit a much greater
preference for a particular activity order. One possible
reason for this is that longer series correspond to
more and more specific protein environments, while
matched pair analysis often suffers from being an aver-
age effect.
It will be shown that it is possible to predict, with a
known degree of accuracy, what R group should increase/
decrease the activity of interest, given an observed order-
ing of activities for a matched series (Figure 1). Predictions
are wholly knowledge-based and interpretable.
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Figure 1 Observed ordering of activities for a matched series.
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